Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
RGEN
11.93%
▼ -2.89%
BIO
-0.09%
▼ -1.24%
Gross Margin
RGEN
53.08%
▲ 2.38%
BIO
53.12%
▲ 0.86%
Free Cash Flow
RGEN
$27.67M
▲ $4.32M
BIO
$66.70M
▼ -$11.40M
Net Debt / EBITDA
RGEN
-0.98
▼ -0.42
BIO
-0.78
▼ -0.38
Operating Margin
RGEN
5.84%
▼ -3.42%
BIO
11.15%
▲ 5.39%
P/E Ratio
RGEN
191.71
▲ 53.82
BIO
40.03
▼ -4.70